Join the Breast Cancer, Metastatic group to help and get support from people like you.
Breast Cancer, Metastatic News (Page 4)
Related terms: Metastatic Breast Cancer
Upward Trends in Breast Cancer Incidence Continuing Among Women
TUESDAY, Oct. 1, 2024 – Upward trends in breast cancer incidence among women have continued, according to a study published online Oct. 1 in CA: A Cancer Journal for Clinicians. Angela N. Giaquinto,...
Cognitive Behavioral Therapy Program Aids Insomnia in Breast Cancer Survivors
FRIDAY, Sept. 27, 2024 – An in-home, voice-activated cognitive behavioral therapy (CBT) program improves insomnia symptoms among breast cancer survivors, according to a study published online Sept....
Aromatase Inhibitors Not Linked to CAC in Postoperative Breast Cancer Patients
TUESDAY, Sept. 17, 2024 – For postoperative patients with breast cancer, the duration of aromatase inhibitor (AI) treatment is not associated with the risk for coronary artery calcium (CAC),...
Black Women Face Higher Death Risk From All Types of Breast Cancer
WEDNESDAY, Sept. 18, 2024 – Black women have a higher risk of dying from any type of breast cancer than white women, a new review finds. Overall, the increased survival risk for Black women ranges...
FDA Expands Use of Breast Cancer Drug Kisqali
WEDNESDAY, Sept. 18, 2024 – Women with early stage breast cancer may now take Kisquali, a medication already approved for advanced disease, following the U.S. Food and Drug Administration's expanded...
Risk of Contralateral Breast Cancer Lower With Bilateral Mastectomy
MONDAY, July 29, 2024 – For women with unilateral breast cancer, the risk of contralateral breast cancer is lower after bilateral mastectomy, but mortality rates are similar to those after...
Many Breast Cancer Survivors With Indications for Genetic Testing Do Not Receive It
TUESDAY, July 23, 2024 – Many breast cancer survivors with indications for genetic counseling and testing do not receive it, according to a study published online July 15 in the Journal of Clinical ...
FDA Approves Truqap (capivasertib) plus Faslodex for Patients with Advanced HR-Positive Breast Cancer
17 November 2023 – AstraZeneca’s Truqap (capivasertib) in combination with Faslodex (fulvestrant) has been approved in the US for the treatment of adult patients with hormone receptor (HR)-positive, ...
FDA Approves Margenza (margetuximab-cmkb) for Patients with Pretreated Metastatic HER2-Positive Breast Cancer
ROCKVILLE, MD, Dec. 16, 2020 (GLOBE NEWSWIRE) – MacroGenics, Inc. (Nasdaq: MGNX), a biopharmaceutical company focused on developing and commercializing innovative monoclonal antibody-based ...
FDA Approves Phesgo (pertuzumab, trastuzumab, and hyaluronidase-zzxf) for HER2-Positive Breast Cancer
South San Francisco, CA – June 29, 2020 – Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced that the U.S. Food and Drug Administration (FDA) has approved Phesgo,...
FDA Approves Trodelvy (sacituzumab govitecan-hziy) for Previously-Treated Metastatic Triple Negative Breast Cancer
Morris Plains, N.J., April 22, 2020 — Immunomedics, Inc. (NASDAQ: IMMU) (“Immunomedics” or the “Company”), a leading biopharmaceutical company in the area of antibody-drug conjugates (ADC), today anno...
FDA Approves Tukysa (tucatinib) for People with Advanced Unresectable or Metastatic HER2-Positive Breast Cancer
BOTHELL, Wash.--(BUSINESS WIRE) April 17, 2020 – Seattle Genetics, Inc. (Nasdaq:SGEN) today announced the U.S. Food and Drug Administration (FDA) granted approval to Tukysa™ (tucatinib) tablets in c...
FDA Approves Enhertu (fam-trastuzumab deruxtecan-nxki) for HER2-Positive Unresectable or Metastatic Breast Cancer Following Two or More Prior Anti-HER2 Based Regimens
20 December 2019 – AstraZeneca and Daiichi Sankyo Company, Limited (Daiichi Sankyo) today announced that the US Food and Drug Administration (FDA) has approved Enhertu® (fam-trastuzumab ...
FDA Approves Trazimera (trastuzumab-qyyp), a Biosimilar to Herceptin
March 11, 2019 - Pfizer Inc. today announced the United States (U.S.) Food and Drug Administration (FDA) has approved Trazimera (trastuzumab-qyyp), a biosimilar to Herceptin® (trastuzumab),1 for the ...
FDA Approves Herzuma (trastuzumab-pkrb), a Biosimilar to Herceptin
INCHEON, South Korea & JERUSALEM--(BUSINESS WIRE) December 14, 2018 --Celltrion, Inc. and Teva Pharmaceutical Industries Ltd. today announced that the U.S. Food and Drug Administration (FDA) has...
Further information
Related condition support groups
Related drug support groups
anastrozole, letrozole, Herceptin, Arimidex, Femara, trastuzumab, tamoxifen, Ibrance